Yi Ping Li
Patrimonio netto: 2 M $ in data 31/05/2026
Patrimonio netto: 2 M $ in data 31/05/2026
Dr. Yi Ping Li, MD, is a Non-Executive Director at JW (Cayman) Therapeutics Co. Ltd., a Chairman at JW Therapeutics (Shanghai) Co., Ltd. and a Chief Executive Officer & Director at JW Biotechnology (Shanghai) Co. Ltd. He is on the Board of Directors at JW (Cayman) Therapeutics Co. Ltd., JW Biotechnology (Shanghai) Co. Ltd. and GenScript Corp.
Dr. Li was previously employed as a General Manager by Amgen Biotechnology Consulting Shanghai Co., Ltd., a Partner by Kleiner Perkins Caufield & Byers LLC, a Medical Director by Merck Serono SA, and a Partner by KPCB (China) Advisory Co. Ltd. He also served on the board at China Kanghui Holdings.
He received his graduate degree from The University of Montana and a doctorate degree from Shanghai Jiao Tong University.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 07/07/2025 | 9.206.460 ( 2,21% ) | 2 M $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| JW (CAYMAN) THERAPEUTICS CO. LTD | Fondatore | 06/09/2017 |
GenScript Corp.
GenScript Corp. BiotechnologyHealth Technology Provides biological research and drug discovery services to pharmaceutical companies | Direttore/Membro del Consiglio | 27/07/2010 |
JW Biotechnology (Shanghai) Co. Ltd. | Fondatore | - |
JW Therapeutics (Shanghai) Co., Ltd.
JW Therapeutics (Shanghai) Co., Ltd. BiotechnologyHealth Technology Develops cell-based immunotherapies to treat cancer | Fondatore | 01/02/2016 |
| Società | Posizione | Fine |
|---|---|---|
Amgen Biotechnology Consulting Shanghai Co., Ltd. | Amministratore Delegato | 01/07/2015 |
China Kanghui Holdings
China Kanghui Holdings Medical SpecialtiesHealth Technology Researches, develops and distributes orthopedic implants and instruments | Direttore/Membro del Consiglio | 08/11/2010 |
Merck Serono SA
Merck Serono SA Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops drugs for reproductive and metabolism | Corporate Officer/Principal | 30/08/2006 |
Kleiner Perkins Caufield & Byers LLC
Kleiner Perkins Caufield & Byers LLC Investment ManagersFinance Kleiner Perkins Caufield & Byers invests in companies located in the United States. The firm targets companies operating in consumer, enterprise, Fintech, hardtech and healthcare sectors. It provides financing for seed, early, and later stage capital requirements. | Corporate Officer/Principal | - |
KPCB (China) Advisory Co. Ltd.
KPCB (China) Advisory Co. Ltd. Investment ManagersFinance KPCB China Advisory is an active manager which invests in companies located in China. The firm focuses on companies operating in the fields of digital, green tech and life science opportunities. It participates in seed, early and later-stage capital requirements. | Corporate Officer/Principal | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 11 |
|---|---|
Kleiner Perkins Caufield & Byers LLC
Kleiner Perkins Caufield & Byers LLC Investment ManagersFinance Kleiner Perkins Caufield & Byers invests in companies located in the United States. The firm targets companies operating in consumer, enterprise, Fintech, hardtech and healthcare sectors. It provides financing for seed, early, and later stage capital requirements. | Finance |
The University of Montana
The University of Montana Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Shanghai Jiao Tong University
Shanghai Jiao Tong University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Merck Serono SA
Merck Serono SA Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops drugs for reproductive and metabolism | Health Technology |
KPCB (China) Advisory Co. Ltd.
KPCB (China) Advisory Co. Ltd. Investment ManagersFinance KPCB China Advisory is an active manager which invests in companies located in China. The firm focuses on companies operating in the fields of digital, green tech and life science opportunities. It participates in seed, early and later-stage capital requirements. | Finance |
GenScript Corp.
GenScript Corp. BiotechnologyHealth Technology Provides biological research and drug discovery services to pharmaceutical companies | Health Technology |
China Kanghui Holdings
China Kanghui Holdings Medical SpecialtiesHealth Technology Researches, develops and distributes orthopedic implants and instruments | Health Technology |
JW Biotechnology (Shanghai) Co. Ltd. | |
JW Therapeutics (Shanghai) Co., Ltd.
JW Therapeutics (Shanghai) Co., Ltd. BiotechnologyHealth Technology Develops cell-based immunotherapies to treat cancer | Health Technology |
JW (Cayman) Therapeutics Co. Ltd.
JW (Cayman) Therapeutics Co. Ltd. BiotechnologyHealth Technology Operates as biotechnology company that develops and manufactures cell immunotherapy products | Health Technology |
Amgen Biotechnology Consulting Shanghai Co., Ltd. |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale